---

Peter Seeberger

Director, Max-Planck-Institute of Colloids and Interfaces; Professor, Free University of Berlin

“Early on, I received a Fulbright scholarship to perform graduate work at the University of Colorado with Marv Caruthers, the inventor of gene synthesis machines and a co-founder of Amgen. It opened new perspectives and eventually led to my work on automated glycan assembly, which in turn resulted in novel vaccines and diagnostics. My work today focuses on creating vaccines to protect everybody from deadly infectious diseases, and new methods to produce affordable drugs.”

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018